Formononetin Inhibited the Inflammation of LPS-Induced Acute Lung Injury in Mice Associated with Induction of PPAR Gamma Expression
- 743 Downloads
Formononetin has shown a variety of pharmacologic properties including anti-inflammatory effect. In the present study, we analyzed the role of formononetin in acute lung injury induced by lipopolysaccharide (LPS) in mice. The cell counting in the bronchoalveolar lavage fluid (BALF) was measured. The animal lung edema degree was evaluated by wet/dry weight ratio. The superoxidase dismutase (SOD) activity and myeloperoxidase (MPO) activity was assayed by SOD and MPO kits, respectively. The levels of inflammatory mediators, tumor necrosis factor-α (TNF-α) and IL-6,were assayed by enzyme-linked immunosorbent assay method. Pathological changes of hung tissues were observed by HE staining. Peroxisome proliferator-activated receptor (PPAR)-γ gene expression was measured by real-time PCR. The data showed that treatment with the formononetin group markedly attenuated inflammatory cell numbers in the BALF, increased PPAR-γ gene expression and improved SOD activity and inhibited MPO activity. The histological changes of the lungs were also significantly improved by formononetin compared to LPS group. The results indicated that formononetin has a protective effect on LPS-induced acute lung injury in mice.
KEY WORDSformononetin inflammation PPAR-γ LPS-induced acute lung injury
This work was supported by Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
- 2.Worthen, G.S., C. Haslett, A.J. Rees, R.S. Gumbay, J.E. Henson, and P.M. Henson. 1987. Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung. The American Review of Respiratory Disease 136: 19–28.PubMedCrossRefGoogle Scholar
- 6.Benayoun, L., S. Letuve, A. Druilhe, et al. 2001. Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. American Journal of Respiratory and Critical Care Medicine 164(8 I): 1487–1494.PubMedCrossRefGoogle Scholar
- 8.Spinelli, S.L., J.J. O’Brien, and S. Bancos, et al. 2008. The PPAR platelet connection: modulators of inflammation and potential cardiovascular effects. PPAR Research vol. 2008, Article ID 328172, 16 pages.Google Scholar
- 13.Valentina, P., C.L. Marchica, and M.S. Ludwig. 2009. Physiology &Neurobiology 169: 36–43.Google Scholar
- 15.Knapp, S., S. Florquin, D.T. Golenbock, and T. van der Poll. 2006. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. Journal of Immunology 176: 3189–3195.Google Scholar
- 18.Wang, Q., P. Teder, N.P. Judd, P.W. Noble, and C.M. Doerschuk. 2002. CD44 Deficiency leads to enhanced neutrophil migration and lung injury in escherichia coli pneumonia in mice. The American Journal of Pathology 161: 2219–2228.Google Scholar